Dr. Gina Vaccaro, MD

  • Chattanooga, TN
  • Medical oncologist
NPI1700960671PAC ID5799755179
Medicare services, 2024
53,487
Medicare patients, 2024
349
Part D claims, 2024
607
Clinical trials
1
MIPS score, 2024
93
Practice address
605 Glenwood Dr, Chattanooga, TN 37404
Practice phone
Call (615) 329-0570
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Tennessee Oncology

Chattanooga, Tennessee

See all 8 affiliations

Find Dr. Vaccaro's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gina Vaccaro is a medical oncologist in Chattanooga, Tennessee

Dr. Vaccaro practices at Tennessee Oncology in Chattanooga, Tennessee.

Dr. Vaccaro's NPI, 1700960671, was assigned on October 25, 2006. Dr. Vaccaro graduated from Louisiana State University School of Medicine in New Orleans in 2001. Dr. Vaccaro holds Oregon license MD28681.

NPI and contact details
Medicare PAC ID
5799755179
NPI enumeration date
October 25, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(615) 329-0570
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Gina Vaccaro practices at Tennessee Oncology in Chattanooga, Tennessee

Dr. Vaccaro's primary practice is Tennessee Oncology, at 605 Glenwood Dr, Chattanooga, TN 37404 in Hamilton County. The practice phone is (615) 329-0570.

  • Tennessee Oncology
    605 Glenwood Dr, Chattanooga, TN 37404 · Hamilton CountyPhone(615) 329-0570

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Gina Vaccaro is affiliated with 5 sites of care and 3 medical groups

Dr. Vaccaro's primary practice is Tennessee Oncology in Chattanooga, Tennessee. Dr. Vaccaro is also affiliated with Cookeville Regional Medical Center. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Vaccaro to 1 more hospital, 2 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

See all 8 affiliations for Dr. Vaccaro

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Gina Vaccaro's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaccaro practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Tennessee OncologyAvailable with a free account
+4 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Vaccaro practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gina Vaccaro is one of 99 medical oncologists in Tennessee

Medical oncology is Dr. Vaccaro's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Vaccaro's licenses on file in 2 states: Oregon and North Carolina.

Specialties and state licenses

  • Medical oncology, OregonPrimaryLicense MD28681 · taxonomy 207RX0202X
  • Hematology and oncology, North CarolinaLicense 2004-00613 · taxonomy 207RH0003X

Medical oncologists near Dr. Vaccaro

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gina Vaccaro billed Medicare for 53,487 services in 2024

CMS data shows 53,487 Medicare services from Dr. Vaccaro across 60 procedure codes in 2024, for 349 Medicare patients. Medicare paid $365,119 for them. Every service was in an office.

Medicare services, 202453,487
Medicare patients349
Paid by Medicare$365,119
Procedure codes60

Dr. Vaccaro's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 02024: 47,593
Lab and pathology
2023: 02024: 2,366
Tests and treatments
2023: 02024: 1,850
Office and hospital visits
2023: 2542024: 727186%
Surgery
2023: 02024: 612
Other services
2023: 352024: 339869%

Dr. Vaccaro compared with the Tennessee median for medical oncologists, 2024

  • Dr. Vaccaro
  • Tennessee median
Medicare services
53,487vs 1,19444.8 times
Medicare patients
349vs 23449% above
Part D claims
372vs 370Close to median

Medians across 94 medical oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Vaccaro's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vaccaro

Need commercial claims for Dr. Vaccaro?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vaccaro and other medical oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Gina Vaccaro treated 349 Medicare patients in 2024, average age 73

CMS counts 349 Medicare patients who saw Dr. Vaccaro in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaccaro's median patient age at 69, with 60% women.

Medicare patients, 2024349
Average age73
Average risk score1.66
Also on Medicaid12%

Dr. Vaccaro's Medicare patients by age, 2024

Dr. Vaccaro's Medicare patients by sex, 2024

  • Women19456%
  • Men15544%

Chronic conditions among Dr. Vaccaro's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol74%
  3. Arthritis57%
  4. Cancer42%
  5. Diabetes35%
  6. Chronic kidney disease34%
  7. Ischemic heart disease33%
  8. Mood disorders33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vaccaro's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women60%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Gina Vaccaro wrote 607 Medicare Part D claims in 2024

In 2024, Dr. Vaccaro wrote 607 Medicare Part D claims for 153 patients. 83% of them were for generic drugs. CMS names the drug for 372 of them, across 11 drugs with 11 or more claims each, at $27,707 in total drug cost. In 2023, CMS named 606 claims across 17 drugs.

Part D claims, 2024607
Drugs named by CMS11
Total drug cost$27,707
Part D patients153

Dr. Vaccaro's Part D claims by kind of drug, 2024

  • Generic506 claims83%
  • Brand-name101 claims17%

Dr. Vaccaro's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vaccaro's Part D claims, 2024

  • Opioids8%48 of 607 claims
  • Antibiotics2%13 of 607 claims
  • Antipsychotics, patients 65 and over7%41 of 607 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6062024: 37239%

Drugs named by CMS: 11 in 2024, 17 in 2023.

See all prescribing by Dr. Vaccaro

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Gina Vaccaro scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vaccaro for performance year 2024, reported as part of a group. Dr. Vaccaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Vaccaro's MIPS scores, performance year 2024

  • 93of 100Final score
  • 89of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Vaccaro by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gina Vaccaro has worked on 1 clinical trial

Dmand AI links Dr. Vaccaro to 1 clinical trial. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Open Payments lists research payments to Dr. Vaccaro that name 1 trial.

Conditions in Dr. Vaccaro's trials

  • Lupus Erythematosus, Systemic
  • Connective Tissue Diseases

Investigators on the most trials with Dr. Vaccaro

Recent clinical trials with Dr. Vaccaro

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gina Vaccaro received $254,192 in industry payments from 2016 to 2025

CMS Open Payments shows 557 general payments to Dr. Vaccaro from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Incyte Corporation paid the most, $185,820. It also lists 2 research payments totaling $243 from 2016 to 2023, naming 1 clinical trial.

General payments to Dr. Vaccaro by program year, 2016 to 2025

General payments to Dr. Vaccaro by kind, 2016 to 2025

$254.2Kin total
  • Speaker and faculty fees$180,91271%
  • Travel and lodging$33,44813%
  • Consulting fees$26,11910%
  • Food and beverage$12,9435%
  • Education$7700%

Companies that paid Dr. Vaccaro the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vaccaro

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Gina Vaccaro graduated from Louisiana State University School of Medicine in New Orleans

Dr. Vaccaro graduated from Louisiana State University School of Medicine in New Orleans in 2001.

  1. Medical schoolLouisiana State University School of Medicine in New Orleans

Source: Dmand AI Professional Profile Data

Sources for Dr. Gina Vaccaro's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gina Vaccaro

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gina Vaccaro's NPI number?

Dr. Gina Vaccaro's NPI number is 1700960671. It was assigned on October 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Gina Vaccaro?

Dr. Gina Vaccaro is a medical oncologist in Chattanooga, Tennessee. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Gina Vaccaro practice?

Dr. Vaccaro practices at 605 Glenwood Dr, Chattanooga, TN 37404. Dr. Vaccaro's primary practice is Tennessee Oncology in Chattanooga, Tennessee. Dmand AI also links Dr. Vaccaro to 1 hospital, 2 medical groups, 1 group practice or clinic and 1 home health agency.

What is Dr. Gina Vaccaro's office phone number?

The practice phone on file for Dr. Vaccaro is (615) 329-0570.

What is Dr. Gina Vaccaro's medical license number?

Dr. Vaccaro holds Oregon license MD28681, one of the licenses on file in 2 states.

Which states has Dr. Gina Vaccaro been licensed in?

Dmand AI has state licenses on file for Dr. Vaccaro in Oregon and North Carolina.

Which hospitals is Dr. Gina Vaccaro affiliated with?

Dr. Vaccaro is affiliated with Cookeville Regional Medical Center. Dmand AI links Dr. Vaccaro to 1 more hospital.

What medical group is Dr. Gina Vaccaro part of?

Dr. Vaccaro is linked to Tennessee Oncology. Dmand AI links Dr. Vaccaro to 2 more medical groups.

Does Dr. Gina Vaccaro accept Medicare?

Yes. CMS data shows Dr. Vaccaro billed Medicare for 53,487 services in 2024, and Dr. Vaccaro accepts Medicare assignment.

What is Dr. Gina Vaccaro's MIPS score?

Dr. Vaccaro's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Gina Vaccaro see?

CMS counts 349 Medicare patients who saw Dr. Vaccaro in 2024, with an average age of 73.

What services does Dr. Gina Vaccaro bill to Medicare?

In 2024, Dr. Vaccaro's most billed Medicare services were injected or infused drug (J9263), injected or infused drug (J1453) and injected or infused drug (J9267).

Where did Dr. Gina Vaccaro go to medical school?

Dr. Vaccaro graduated from Louisiana State University School of Medicine in New Orleans in 2001.

What drugs does Dr. Gina Vaccaro prescribe most?

In 2024 Medicare Part D data, Dr. Vaccaro's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron ODT and Olanzapine.

Has Dr. Gina Vaccaro received payments from drug or device companies?

CMS Open Payments shows $254,192 in general payments to Dr. Vaccaro from 57 companies from 2016 to 2025. The largest total came from Incyte Corporation.

How long has Dr. Gina Vaccaro been practicing?

Dr. Vaccaro graduated from medical school in 2001, 25 years ago.

Does Dr. Gina Vaccaro do research?

Dr. Vaccaro has worked on 1 clinical trial.

Selling to medical oncology practices?

See medical oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)